Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / COM
-
Number of holders
-
43
-
Total 13F shares, excl. options
-
2,609,308
-
Shares change
-
+822,986
-
Total reported value, excl. options
-
$20,143,986
-
Value change
-
+$6,336,492
-
Number of buys
-
22
-
Number of sells
-
-16
-
Price
-
$7.72
Significant Holders of GYRE THERAPEUTICS, INC. - COM (GYRE) as of Q1 2025
47 filings reported holding GYRE - GYRE THERAPEUTICS, INC. - COM as of Q1 2025.
GYRE THERAPEUTICS, INC. - COM (GYRE) has 43 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,609,308 shares
.
Largest 10 shareholders include VANGUARD GROUP INC (1,096,488 shares), BlackRock, Inc. (547,210 shares), GEODE CAPITAL MANAGEMENT, LLC (312,319 shares), STATE STREET CORP (128,773 shares), SBI Securities Co., Ltd. (123,629 shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (111,416 shares), NORTHERN TRUST CORP (108,010 shares), UBS Group AG (24,306 shares), AMERICAN CENTURY COMPANIES INC (23,825 shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (16,931 shares).
This table shows the top 43 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.